J&J Must Face Revived Risperdal Labeling Claims In Calif.
A California appeals court has reinstated claims against Johnson & Johnson and its subsidiaries alleging the antipsychotic drug Risperdal causes gynecomastia, a condition that causes abnormal enlargement of breasts in males,...To view the full article, register now.
Already a subscriber? Click here to view full article